Sfoglia per AUTORE
VIGNANI F
Collezione AOU San Luigi di Orbassano

  

Items : 25

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13
2024
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Ferrari G; Paratore C; Valsecchi AA;

TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Apr;22(2):56-67.e16. doi: 10.1016/j.clgc.2023.08.006. Epub 2023 Sep 7.
2024
ASL Cuneo 2
ASL Asti
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Tucci M; Gennari A; Maio MD; Buttigliero C; Ortega C; Rossi M; Vellani G; Airoldi M; Vormola R; Numico G; Depetris I; Comandone A; Buosi R; Stevani I; Guglielmini P; Icardi M; Dionisio R; Cattrini C; Vignani F; Brusa F; Prati V; Ruatta F; Filippi R; Mennitto A; Vana F; Fea E; Vanella P; Pisano C; Turco F; et alii...

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Bungaro M; Vignani F; Samuelly A; DI Stefano RF; Turco F; Tucci M; Pisano C;

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Tucci M; Gamba T; Necchi A; Buttigliero C; Vignani F; Marandino L;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.
2020
AOU Alessandria
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Pisano C; Vignani F; Di Stefano RF; Tucci M; Sonetto C; Buttigliero C;

Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Polimeno L; Pozzi D; Fusco L; Florio S; Codegone F; Comite R; Chiotto P; Ciriolo G; Audisio M; Ballaminut D; Bellezza A; Zichi C; De Luca E; Vignani F; Sperti E; Lacidogna G; Turco CGC; Guida G; Baratelli C; Marino D; Zilio E; Terzolo S; Di Maio M;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Scagliotti GV; Vignani F; Tabbò F; Turco F; Di Stefano RF; Buttigliero C; Pisano C; Leone G;

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.
2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Polimeno L; Fusco L; Florio S; Codegone F; Comite R; Ciriolo G; Chiotto P; Bellezza A; Ballaminut D; Audisio M; De Luca E; Zichi C; Marino D; Vignani F; Sperti E; Lacidogna G; Turco CGC; Baratelli C; Pozzi D; Zilio E; Terzolo S; Di Maio M;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Ardizzoni A; Zichi C; Gatto L; Vignani F; Tucci M; Buttigliero C; De Luca E; Di Nunno V; Massari F;

Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Pignataro D; Vignani F; DI Stefano RF; Zichi C; Leone G; Buttigliero C; Tucci M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperti E; Marcato M; Bria E; Vignani F; Bironzo P; Baratelli C; Di Maio M; Roila F;

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Vignani F; Buttigliero C; Zichi C; Tucci M; Di Maio M;

Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.
2017
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Aroasio E; Buttigliero C; Berruti A; Bertaglia V; Tucci M; Vignani F;

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Vignani F; Tucci M; Buttigliero C;

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C; Di Maio M;

Rediscovering Secondary Tumors of the Prostate in the Molecular Era. in Advances in anatomic pathology / Adv Anat Pathol. 2016 May;23(3):170-9. doi: 10.1097/PAP.0000000000000115.
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sciarra A; Guerini-Rocco E; Fusco N; Marchiò C; Vignani F; Colombo P; Ferrero S;

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
2016
AOU San Luigi di Orbassano

Vignani F; Bertaglia V; Buttigliero C; Tucci M; Scagliotti GV; Di Maio M;

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. in European urology / Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28.
2016
AOU San Luigi di Orbassano

Scagliotti GV; Porpiglia F; Fiori C; Buttigliero C; Vignani F; Tucci M; Bertaglia V; Di Maio M;

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. in Endocrine / Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15.
2015
AOU San Luigi di Orbassano

Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A;

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.
2015
AOU San Luigi di Orbassano

Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. in Cancer treatment reviews / Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31.
2015
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Bertaglia V; Vignani F; Bironzo P; Di Maio M; Scagliotti GV;

Metastatic castration-resistant prostate cancer: time for innovation. in Future oncology (London, England) / Future Oncol. 2015;11(1):91-106. doi: 10.2217/fon.14.145.
2015
AOU San Luigi di Orbassano

Tucci M; Scagliotti GV; Vignani F;

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. in Cancer treatment reviews / Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10.
2013
AOU San Luigi di Orbassano

Pia A; Vignani F; Attard G; Tucci M; Bironzo P; Scagliotti G; Arlt W; Terzolo M; Berruti A;

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. in Open access journal of urology / Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573.
2010
AOU San Luigi di Orbassano

Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte